Data Source:
In February 2022, the National Cancer Center issued the "2016 China Cancer Incidence and Death Statistics".

ADME

ADME Third Immune Defense Test

Detection Content

Service Advantage

conveniences

Only need to draw peripheral blood

immediacy

Response detects the person's current physical condition

collectivity

The multi-level and multi-parameter immune defense capability detection information was collected and sorted through the big data platform of APAIke

duality

Numerical quantification of immune defense ability; To characterize the strength level of immune defense ability

integrality

Provide multi-dimensional analysis of immune defense capabilities, provide assessment suggestions, and continue to call back

Applicable Population

Aclass

General population
18-75 years old

Bclass

High risk group
Patients with underlying medical conditions

Third immune defense test Please consult your health care provider for details